Navigation Links
Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed

CHICAGO, June 05, 2007 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute's Philip A. Philip, M.D., Ph.D. F.R.C.P., professor of medicine and oncology, presented the outcome of one of the largest randomized phase III pancreas cancer clinical trials in North America and chaired an education session about the future of pancreatic cancer therapies at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL.

The clinical trial, A Phase III Randomized Open-Label Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine as First-Line Therapy of Patients with Advanced Pancreas Cancer, questioned the benefit of using Cetuximab to target the epidermal growth factor receptor (EGFR) in advanced pancreatic cancer patients.

The EGFR is a protein found on the surface of some cancer cells and to which the epidermal growth factor binds, causing uncontrolled cell division -- a predisposition for cancer. The EGFR is found at abnormally high levels on the surface of most pancreatic cancer cells. This study examined the effectiveness of Cetuximab, an anticancer monoclonal antibody directed to block the EGFR, combined with the standard chemotherapy agent Gemcitabine prescribed for patients with advanced pancreatic cancer.

Over 760 pancreatic cancer patients, throughout the U.S. and Canada, participated in the study which compared outcomes of Gemcitabine coupled with Cetuximab as first-line chemotherapy against single-agent Gemcitabine.

"Contrary to previous hypotheses, our study found Cetuximab, along with Gemcitabine, did not offer increased benefits in treating a patient's pancreatic cancer," said Dr. Philip.

Initiated by the Southwest Oncology Group, this study was a substantial accomplishment for the group, concluding two years earlier than their initial five-year goal.

"We were able to gather definitive answers in a shorter amount of time, al
'"/>




Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

Post Your Comments:
(Date:11/25/2009)...Newswire-FirstCall/--HeskaCorporation(HSKA);("Hesk...altyproductstotheveterinaryindustry,announcedtoday...plyofbloodgasproductsandaffiliatedconsumablesforth....com/cgi-bin/prnh/20000622/HESKALOGO ) ,, "Hesk...dofadvancedpoint-of-carediagnostics,"commentedMich...
(Date:11/25/2009)...ire/--BioTrendsResearchGroup,Inc.releasedWave1ofit...amulti-phasesyndicatedmarketresearchprojecttrackin...ductlaunchthroughthefirstsixmonthsofavailability.E...rom75uniqueDermatologistsandqualitativeinformation...ra,obstaclestouse,typicalpatienttypes,productperce...
(Date:11/25/2009).../PRNewswire/--RegadoBiosciences,aprivatelyheldcomp...thactivecontrolagents,announcedthatDavidMazzo,PhD,...1stAnnualHealthCareConferenceattheNewYorkPalaceHot...t1:10pm(EST)onTuesday,December1andwillincludeanove...velopmentprogram,theanticoagulantsystem,REG1.Thehe...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Hospital Workers May Trigger Dangerous Outbreaks 59765 1Hospital Workers May Trigger Dangerous Outbreaks 59765 2Hospital Workers May Trigger Dangerous Outbreaks 59765 3Resident physicians seldom trained in skin cancer examination 59762 1Resident physicians seldom trained in skin cancer examination 59762 2Thyroid surgery safe for older patients study finds 59759 1Thyroid surgery safe for older patients study finds 59759 2Thyroid surgery safe for older patients study finds 59759 3
...ican Association of Pharmaceutical Scientists (AAP...ff in San Diego November 11 - 15, SAN DIEGO, Nov....al Scientists Annual Meeting and Exposition starts...rmaceutical scientists from across the,globe prese...ing -- which marks the largest AAPS meeting to dat...
...y Also Demonstrated Significant Improvement in Eye...sone furoate),Nasal Spray demonstrated significant...allergy symptoms of perennial allergic rhinitis (P...ng to a clinical study presented,today at the annu...llergy,Asthma & Immunology (ACAAI). Perennial all...
Other Medicine Technology:Male Birth Control Pill, Blackberry Extract for Gingivitis, Skin Cancer and Digestive Health Top List of New Medical Discoveries 2Male Birth Control Pill, Blackberry Extract for Gingivitis, Skin Cancer and Digestive Health Top List of New Medical Discoveries 3New Data Shows Veramyst Effectively Treats Symptoms of Perennial Allergic Rhinitis 2New Data Shows Veramyst Effectively Treats Symptoms of Perennial Allergic Rhinitis 3New Data Shows Veramyst Effectively Treats Symptoms of Perennial Allergic Rhinitis 4
(Date:11/26/2009)... Benton Communications announces a highly...em for retailers struggling to make an economic re...r 26, 2009 -- Flu fears is the type of challenge t...cy room, according to Dr. David Benton, business g...ness growth system – The Rfactor Intensive ...
(Date:11/25/2009)...ndCALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc....I)coilsandsoftwareandCalgaryScientificInc.,aleadin...ucedawebversionofAegis(TM)Breast4DAdvancedVisualiz...irsttrulyzero-footprintWebclientbasedmedicalimagin...)platformallowsforzero-footprintaccess-requiringno...
(Date:11/25/2009)...ISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityManag...pare the Air Alert forThursday,November...anyothersolidfuel,bothindoorsandoutdoors. ,, "C...ytomorrow,"saidJackBroadbent,executiveofficerofthe...hehealthoftheirneighborsandfellowcommunitymemberst...
(Date:11/25/2009)...crease blood pressure? This simple question has b... New Stress-related gene Modulates High Blood Pres...essure? This simple question has been the focus o...ch has for the first time established a link betwe... response to stress in mice as well as humans. The...
(Date:11/25/2009)...plagued by neurological symptoms, study finds , ...Neurological side effects are among the potential ...r cancer who were treated with cisplatin-based che...ncluded 1,409 Norwegian men treated for unilateral...part in a follow-up survey conducted from 1998 to ...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
... drive against the malnutrition among the children...lth fairs in villages where around 80,000 malnouri...on diet. // The month-long fairs, organised ...age in Indore district. "The drive will go ...
...(if the man is the biological father of his child)...an idle gossip or as a detailed discussion by anth... (University of Oklahoma and the Centre for Applie... suspicions of whether or not they are a child's b...
...oon becoming infamous with being the leading cause...1.2 million fresh cases every// year that includes...g to recent research, the most common type of lung...ed optimism with this finding, which will hold a c...
...particular diet can influence corrective behaviour...ggression is largely a product of poor nutrition w...g researchers are studying whether prsioners becom...ity”, raised this debate, in 2001, Dr. Joseph Hibb...
...ning out to carry out tests to determine the effic...local media reported on Sunday. The program design...fort by the Department of Medical Sciences, Mahido...e any guidelines on this new technology and was un...
...r body have a great number of genes that are safel...es. According to estimates, only 10% of the // nea...rt state in a particular cell, the rest are only l...cover for the genome from viruses, and even cancer...
Other Medicine News:Health News:Drive Against Malnutrition Among Children In MP Gets Kicked Off 2Health News:Can Men Gauge Biological Paternity Accurately 2Health News:Novel method conceived, to achieve genome-wide gene silencing. 2
Arm Compression Garment
Short-Sleeve Bolero
Compression Arm Sleeves Bolero
Breast Wrap I
Medicine Products: